Acelyrin (SLRN) Short Interest Ratio & Short Volume → Three basic steps to building the Ultimate Dividend Portfolio. (From DTI) (Ad) Free SLRN Stock Alerts $4.34 +0.04 (+0.93%) (As of 01:14 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Acelyrin Short Interest DataCurrent Short Interest8,530,000 sharesPrevious Short Interest7,850,000 sharesChange Vs. Previous Month+8.66%Dollar Volume Sold Short$35.66 millionShort Interest Ratio6.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares99,030,000 sharesFloat Size61,350,000 sharesShort Percent of Float13.90%Today's Trading Volume269,462 sharesAverage Trading Volume1,135,099 sharesToday's Volume Vs. Average24% Short Selling Acelyrin ? Sign up to receive the latest short interest report for Acelyrin and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRN Short Interest Over TimeSLRN Days to Cover Over TimeSLRN Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Acelyrin Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,530,000 shares $35.66 million +8.7%13.9%6.9 $4.18 4/15/20247,850,000 shares $43.33 million -1.3%12.8%6.3 $5.52 3/31/20247,950,000 shares $53.66 million -5.5%13.0%6.3 $6.75 3/15/20248,410,000 shares $65.93 million +21.4%14.0%6.8 $7.84 2/29/20246,930,000 shares $58.56 million +3.6%11.5%6.1 $8.45 2/15/20246,690,000 shares $50.38 million +3.7%11.1%5.6 $7.53 1/31/20246,450,000 shares $49.15 million No Change10.5%5.5 $7.62 SLRN Short Interest - Frequently Asked Questions What is Acelyrin's current short interest? Short interest is the volume of Acelyrin shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 8,530,000 shares of SLRN short. 13.90% of Acelyrin's shares are currently sold short. Learn More on Acelyrin's current short interest. What is a good short interest ratio for Acelyrin? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLRN shares currently have a short interest ratio of 7.0. Learn More on Acelyrin's short interest ratio. Which institutional investors are shorting Acelyrin? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Acelyrin: Capstone Investment Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Acelyrin? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.90% of Acelyrin's floating shares are currently sold short. Is Acelyrin's short interest increasing or decreasing? Acelyrin saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 8,530,000 shares, an increase of 8.7% from the previous total of 7,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acelyrin's float size? Acelyrin currently has issued a total of 99,030,000 shares. Some of Acelyrin's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acelyrin currently has a public float of 61,350,000 shares. How does Acelyrin's short interest compare to its competitors? 13.90% of Acelyrin's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acelyrin: Mereo BioPharma Group plc (2.02%), Lexicon Pharmaceuticals, Inc. (9.52%), Theravance Biopharma, Inc. (14.10%), PepGen Inc. (1.66%), Larimar Therapeutics, Inc. (6.11%), Biomea Fusion, Inc. (50.32%), Neurogene Inc. (8.85%), Fulcrum Therapeutics, Inc. (4.83%), Oculis Holding AG (0.20%), Heron Therapeutics, Inc. (18.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Acelyrin stock? Short selling SLRN is an investing strategy that aims to generate trading profit from Acelyrin as its price is falling. SLRN shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acelyrin? A short squeeze for Acelyrin occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRN, which in turn drives the price of the stock up even further. How often is Acelyrin's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MREO Short Squeeze LXRX Short Squeeze TBPH Short Squeeze PEPG Short Squeeze LRMR Short Squeeze BMEA Short Squeeze NGNE Short Squeeze FULC Short Squeeze OCS Short Squeeze HRTX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRN) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss Ratings4 Cryptos BETTER than BitcoinTrue Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star